{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:14:15Z","timestamp":1781842455437,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jasc.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:33:22Z","timestamp":1697200402000},"page":"23-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Binary subclassification scheme (AUS-Nuclear versus AUS-Other) adequately risk-stratifies thyroid fine needle aspiration specimens classified as Atypia of Undetermined Significance"],"prefix":"10.1016","volume":"13","author":[{"given":"Yaileen D.","family":"Guzm\u00e1n-Arocho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-5652","authenticated-orcid":false,"given":"Paul A.","family":"VanderLaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4692-4981","authenticated-orcid":false,"given":"Michiya","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2023.10.001_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/dc.24859","article-title":"The evolution of \u201catypia\u201d in thyroid fine-needle aspiration specimens","volume":"50","author":"Kim","year":"2022","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib2","first-page":"1039","article-title":"The 2023 Bethesda System for Reporting Thyroid Cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2023.10.001_bib3","series-title":"The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes","author":"Ali","year":"2018"},{"key":"10.1016\/j.jasc.2023.10.001_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s40618-021-01526-3","article-title":"Cancer prevalence in the subcategories of the indeterminate class III (AUS\/FLUS) of the Bethesda system for thyroid cytology: a meta-analysis","volume":"44","author":"Crescenzi","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jasc.2023.10.001_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cncy.21827","article-title":"Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes","volume":"125","author":"Baca","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cncy.21823","article-title":"Thyroid cytology-nuclear versus architectural atypia within the \u201catypia of undetermined significance\/follicular lesion of undetermined significance\u201d Bethesda category have significantly different rates of malignancy","volume":"125","author":"Gan","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/dc.21790","article-title":"Thyroid follicular lesion of\u00a0undetermined significance: evaluation of the risk of malignancy using the two-tier sub-classification","volume":"40","author":"Horne","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ajcp\/aqy109","article-title":"A proposal for separation of nuclear atypia and architectural atypia in Bethesda category III (AUS\/FLUS) based on differing rates of thyroid malignancy","volume":"151","author":"Johnson","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/cyt.12352","article-title":"Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS\/FLUS) category in the Bethesda system for reporting thyroid cytopathology","volume":"28","author":"Kim","year":"2017","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2023.10.001_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000333232","article-title":"Spectrum of risk of malignancy in subcategories of 'atypia of undetermined significance'","volume":"55","author":"Olson","year":"2011","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2023.10.001_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cncy.20091","article-title":"Should \u201catypical follicular cells\u201d in thyroid fine-needle aspirates be subclassified?","volume":"118","author":"Renshaw","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cncy.21412","article-title":"Should the thyroid AUS\/FLUS category be further stratified by malignancy risk?","volume":"122","author":"Nishino","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/thy.2013.0650","article-title":"Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda category III): importance of ultrasonography and cytological subcategory","volume":"24","author":"Rosario","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2023.10.001_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000496600","article-title":"An insight into the utility of sub-categorisation of atypia of undetermined significance for risk stratification: a retrospective study on an Indian cohort with histopathological correlation","volume":"63","author":"Roy","year":"2019","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2023.10.001_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/dc.23472","article-title":"Cytologic subclassification of atypia of undetermined significance may predict thyroid nodules more likely to be malignant at surgery","volume":"44","author":"Shrestha","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncy.22228","article-title":"Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: a systematic review and meta-analysis","volume":"128","author":"Vuong","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/cncy.22489","article-title":"Combined molecular and histologic end points inform cancer risk estimates for thyroid nodules classified as atypia of undetermined significance","volume":"129","author":"Onken","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cncy.22684","article-title":"Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: implications for molecular testing and surveillance","volume":"131","author":"Hall","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jasc.2021.10.001","article-title":"Molecular testing results as a quality metric for evaluating cytopathologists' utilization of the atypia of undetermined significance category for thyroid nodule fine-needle aspirations","volume":"11","author":"VanderLaan","year":"2022","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1089\/thy.2020.0969","article-title":"Repeat fine needle aspiration cytology refines the selection of thyroid nodules for Afirma gene expression classifier testing","volume":"31","author":"Nishino","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2023.10.001_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jamaoncol.2018.1446","article-title":"Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features","volume":"4","author":"Nikiforov","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jasc.2023.10.001_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1203208","article-title":"Preoperative diagnosis of benign thyroid nodules with indeterminate cytology","volume":"367","author":"Alexander","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jasc.2023.10.001_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamasurg.2018.1153","article-title":"Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules","volume":"153","author":"Patel","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jasc.2023.10.001_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/cncy.22617","article-title":"Probability of malignancy as determined by ThyroSeq v3 genomic classifier varies according to the subtype of atypia","volume":"130","author":"Gajzer","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jasc.2020.03.004","article-title":"Molecular-derived estimation of risk of malignancy for indeterminate thyroid cytology diagnoses","volume":"9","author":"Ohori","year":"2020","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncy.22737","article-title":"Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV","volume":"131","author":"Tjendra","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2023.10.001_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","article-title":"Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study","volume":"5","author":"Steward","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jasc.2023.10.001_bib28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1089\/thy.2022.0124","article-title":"A retrospective evaluation of the diagnostic performance of an interdependent pairwise MicroRNA expression analysis with a mutation panel in indeterminate thyroid nodules","volume":"32","author":"Finkelstein","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.jasc.2023.10.001_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/thy.2016.0628","volume":"27","author":"Haugen","year":"2017","journal-title":"Thyroid"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294523002302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294523002302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:48:10Z","timestamp":1761979690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294523002302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213294523002302"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2023.10.001","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binary subclassification scheme (AUS-Nuclear versus AUS-Other) adequately risk-stratifies thyroid fine needle aspiration specimens classified as Atypia of Undetermined Significance","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}